The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: dirucotide

BioMS and Lilly Terminate Dirucotide Agreement

Not surprising, given the failure of the SPMS trial (etc.) in July, but Eli Lilly and BioMS have terminated their license and collaboration agreement, with “all commercial rights to dirucotide … returned to BioMS.”  No indication from the press release where BioMS is headed, just that they’re “completing [their] review of the additional dirucotide clinical data and assessing the strategic options available.”  Sigh.

Bookmark and Share


Get every new post delivered to your Inbox.

Join 130 other followers